September 17, 2021
A New Jersey federal judge has approved a $2 million settlement to resolve claims by Indivior PLC investors concerning the drop in the company's stock price following its indictment for downplaying the addictive qualities of its opioid treatment drug, Suboxone.
February 10, 2021
An Indivior PLC investor asked a New Jersey federal court on Tuesday to bless a $2 million settlement resolving proposed class claims that the company's stock plunged amid criminal charges accusing executives of downplaying the addiction potential of opioid treatment drug Suboxone, saying the deal resulted from arm's-length negotiations.
July 31, 2019
The Rosen Law Firm will lead a stock-drop suit it brought against Indivior Inc. in April, weeks after federal prosecutors accused the drug manufacturer of raking in billions by lying to doctors about one of its opioid addiction drugs.